Cohort Study of Insulin Glargine and Risk of Breast, Prostate, and Colorectal Cancer Among Patients With Diabetes

OBJECTIVE: To examine whether use of insulin glargine, compared with another long-acting insulin, is associated with risk of breast, prostate, colorectal cancer, or all cancers combined. RESEARCH DESIGN AND METHODS: Computerized health records from Kaiser Permanente Northern and Southern California...

Descripción completa

Detalles Bibliográficos
Autores principales: Habel, Laurel A., Danforth, Kim N., Quesenberry, Charles P., Capra, Angela, Van Den Eeden, Stephen K., Weiss, Noel S., Ferrara, Assiamira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836110/
https://www.ncbi.nlm.nih.gov/pubmed/24170756
http://dx.doi.org/10.2337/dc13-0140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836110/
https://www.ncbi.nlm.nih.gov/pubmed/24170756
http://dx.doi.org/10.2337/dc13-0140

Ejemplares similares